Effectiveness of a low gonadotrophin-releasing hormone antagonist dose in preventing premature luteinizing hormone rise during controlled ovarian stimulation

By Tiboni Gian Mario   Palumbo Paola   Leonzio Emiliana   Gabriele Elisabetta   Verna Ilde   Giampietro Franca  

Gynecological Endocrinology, Vol. 27, Iss. 11, 2011-11 ,pp. : 885-889

Informa Healthcare

Access to resources Recommend Favorite

Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix

By Ludwig M.   Riethmuller-Winzen H.   Felberbaum R.E.   Olivennes F.   Albano C.   Devroey P.   Diedrich K.  

Fertility and Sterility, Vol. 75, Iss. 1, 2001-01 ,pp. : 18-22

Elsevier

Access to resources Recommend Favorite

Does the Addition of Luteinizing Hormone in Ovarian Stimulation Protocols Improve the Outcome?

By Ludwig Michael  

Treatments in Endocrinology, Vol. 2, Iss. 5, 2003-01 ,pp. : 305-313

Adis International

Access to resources Recommend Favorite

Recombinant luteinizing hormone supplementation to recombinant follicle-stimulation hormone during induced ovarian stimulation in the GnRH-agonist protocol: A meta-analysis

By Oliveira João   Mauri Ana   Petersen Claudia   Martins Anice   Cornicelli João   Cavanha Mario   Pontes Anagloria   Baruffi Ricardo   Franco José  

Journal of Assisted Reproduction and Genetics, Vol. 24, Iss. 2-3, 2007-03 ,pp. : 67-75

Springer Publishing Company

Access to resources Recommend Favorite

Is there a need for recombinant human luteinizing hormone (lutropin alfa) supplementation in ovarian stimulation for assisted reproduction?

By Nawroth Frank   Ludwig Michael  

Women's Health, Vol. 2, Iss. 3, 2006-05 ,pp. : 375-384

Future Medicine

Access to resources Recommend Favorite